Science & Enterprise subscription

Follow us on Twitter

  • A new enterprise, spun off from Seattle Children’s Research Institute, is creating therapeutics for diseases from e… https://t.co/CvnMEFT0Cm
    about 7 hours ago
  • New post on Science and Enterprise: Start-Up Developing Engineered B-Cell Therapies https://t.co/vMgdwnIXdi #Science #Business
    about 7 hours ago
  • Global drug maker Roche Group is acquiring an experimental antiviral therapy for Covid-19 infections taken as a ora… https://t.co/e2d7m6HG1E
    about 10 hours ago
  • New post on Science and Enterprise: Roche Gains Covid-19 Oral Drug Candidate https://t.co/nh27g6uCwi #Science #Business
    about 10 hours ago
  • The day that America lost $100 billion because of an immigration visa ban https://t.co/OfEx6SFwxA via @BrookingsInst
    about 23 hours ago

Please share Science & Enterprise

Gene Therapy Delivery Tech Licensed in $1.8B Deal

DNA puzzle

A biotechnology company creating synthetic viruses with artificial intelligence to deliver gene therapies is licensing its technology to drug maker Roche. . . . → Read More: Gene Therapy Delivery Tech Licensed in $1.8B Deal

NIH Trial Testing Current Drugs to Treat Covid-19

Medical gear

A clinical trial is planned to assess two drugs designed for other medical conditions as treatments for Covid-19 infections. . . . → Read More: NIH Trial Testing Current Drugs to Treat Covid-19

Individual Cells Explored with Virtual Reality

vLume image

A new software package uses virtual reality to allow biologists and medical researchers to visualize and explore inside individual cells in three dimensions. . . . → Read More: Individual Cells Explored with Virtual Reality

Start-Up Gains Access to Vaccine Nasal Spray Technology

Nasal spray

A company developing techniques to deliver vaccines like Covid-19 with a nasal spray received an opportunity to license the process from University of Houston. . . . → Read More: Start-Up Gains Access to Vaccine Nasal Spray Technology

New Funds Advance Hand-Wrist Neural Rehab Device

Neurons illustration

Developers of a system to help people with spinal cord injuries regain use of their hands and wrists, are configuring the device for home use. . . . → Read More: New Funds Advance Hand-Wrist Neural Rehab Device

Process Tests Thousands of Covid-19 Samples at Once

Covid-19 testing

A new technology makes possible simultaneous analysis of diagnostic specimens from thousands of individuals revealing the presence of SARS-CoV-2 coronaviruses. . . . → Read More: Process Tests Thousands of Covid-19 Samples at Once

DoD Funding Mobile Vaccine/Therapy Manufacturing Lab

DNAmolcule model

The U.S. Defense Department’s research agency is funding a prototype mobile lab to produce RNA-based vaccines and therapies in the field on demand. . . . → Read More: DoD Funding Mobile Vaccine/Therapy Manufacturing Lab

Stimulation Device Shown to Reduce Tinnitus Symptoms

Lenire system

Results from a clinical trial show a device that sends audio and electrical signals to the ears and tongue reduces tinnitus symptoms for as long as one year. . . . → Read More: Stimulation Device Shown to Reduce Tinnitus Symptoms

New Company IDs Drugs Targeting Cancer Cell Networks

Cancer magnified

A start-up company is using artificial intelligence to discover drugs that address the tumor stroma, a cellular network supporting cancerous tumors. . . . → Read More: New Company IDs Drugs Targeting Cancer Cell Networks

FDA Bucks White House, Issues Strict Vaccine Guidance

White House

The U.S. Food and Drug Administration yesterday issued guidance for Covid-19 vaccine developers, requiring extended follow-up with clinical trial participants. . . . → Read More: FDA Bucks White House, Issues Strict Vaccine Guidance